Biofield Therapies: Guidelines for Reporting Clinical Trials

被引:1
|
作者
Hammerschlag, Richard [1 ,2 ]
Sprengel, Meredith [3 ]
Baldwin, Ann L. [4 ]
机构
[1] Consciousness & Healing Initiat, 6919 La Jolla Blvd, San Diego, CA 92037 USA
[2] NOVA Inst Hlth, Baltimore, MD USA
[3] Netherlands Org Appl Sci Res TNO, Human Factors, Soesterberg, Netherlands
[4] Univ Arizona, Dept Physiol, Tucson, AZ USA
来源
GLOBAL ADVANCES IN INTEGRATIVE MEDICINE AND HEALTH | 2024年 / 13卷
关键词
biofield therapies; biofield therapy clinical trials; reporting guidelines; RANDOMIZED CONTROLLED-TRIALS; EXTERNAL QIGONG; HEALING TOUCH; QI-THERAPY; RADIATION-THERAPY; DOUBLE-BLIND; CONSORT; REIKI; CANCER; EXTENSION;
D O I
10.1177/27536130231202501
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
A set of guidelines has been developed to help improve reporting of clinical trials of biofield therapies. The need for enhanced transparency when reporting trials of this family of integrative health practices, eg, External Qigong, Healing Touch, Reiki and Therapeutic Touch, has been advocated in systematic reviews of these studies. The guidelines, called Biofield Therapies: Reporting Evidence Guidelines (BiFi REGs), supplement CONsolidated Standards of Reporting Trials (CONSORT) 2010 by including details of the intervention protocols relevant to biofield therapy trials. BiFi REGs evolved through a draft document created by a core group, two rounds of a Delphi process with an international group of subject matter experts and two panels, meeting via Zoom, which included editors of complementary and integrative medicine journals. BiFi REGs comprises a 15-item Intervention checklist. Modifications of two other CONSORT topic areas are also proposed to enhance their relevance to trials of biofield therapies. Included for each item are an explanation, and exemplars of reporting from peer-reviewed published reports of biofield therapy trials. When used in conjunction with all other items from CONSORT 2010, we anticipate that BiFi REGs will expedite the peer review process for biofield therapy trials, facilitate attempts at trial replication and help to inform decision-making in the clinical practice of biofield therapies.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies
    Bonsu, Janice M.
    Guha, Avirup
    Charles, Lawrence
    Yildiz, Vedat O.
    Wei, Lai
    Baker, Brandee
    Brammer, Jonathan E.
    Awan, Farrukh
    Lustberg, Maryam
    Reinbolt, Raquel
    Miller, Eric D.
    Jneid, Hani
    Ruz, Patrick
    Carter, Rebecca R.
    Milks, Michael W.
    Paskett, Electra D.
    Addison, Daniel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (06) : 620 - 628
  • [42] Reporting of Postprotocol Therapies and Attrition in Multiple Myeloma Randomized Clinical Trials A Systematic Review
    Mohyuddin, Ghulam Rehman
    Koehn, Kelly
    Abdallah, Al-Ola
    Goodman, Aaron M.
    Prasad, Vinay
    JAMA NETWORK OPEN, 2021, 4 (04)
  • [43] Biofield Therapies: Energy Medicine and Primary Care
    Rindfleisch, J. Adam
    PRIMARY CARE, 2010, 37 (01): : 165 - +
  • [44] Randomised trials, human nature, and reporting guidelines
    Schulz, KF
    LANCET, 1996, 348 (9027): : 596 - 598
  • [45] Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: Reporting extended results from Phase III clinical trials
    Goodkin, DE
    Reingold, S
    Sibley, W
    Wolinsky, J
    McFarland, H
    Cookfair, D
    Lublin, F
    ANNALS OF NEUROLOGY, 1999, 46 (01) : 132 - 134
  • [46] Developing guidelines for reporting embedded recruitment trials
    Madurasinghe, Vichithranie W.
    Eldridge, Sandra
    Forbes, Gordon
    TRIALS, 2015, 16
  • [47] Developing guidelines for reporting embedded recruitment trials
    Vichithranie W Madurasinghe
    Sandra Eldridge
    Gordon Forbes
    Trials, 16 (Suppl 2)
  • [48] Guidelines for the reporting of clinical research
    Harvey, L. A.
    SPINAL CORD, 2014, 52 (11) : 787 - 787
  • [49] Guidelines for the reporting of clinical research
    L A Harvey
    Spinal Cord, 2014, 52 : 787 - 787
  • [50] GUIDELINES FOR REPORTING OUTCOMES OF LYMPHOMA TRIALS - REPLY
    DIXON, DO
    MCLAUGHLIN, P
    HAGEMEISTER, FB
    FREIREICH, EJ
    CABANILLAS, FF
    GEHAN, EA
    JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) : 560 - 560